HUVEC cells
Catalog #:
P0027001Shipping advice:
Use only Express Delivery (overnight) for cell lines. International shipping rate please contact us for details
| Frozen vial | USD420.0 |
 |
 |
Origin:
Normal, derived from unbilical veinSpecies:
Homo sapiensTissue:
Vascular endotheliumMorphology:
EpithelialProperties:
AdherentMedium:
Use AddexBio Endlothelial Cell Growth Medium (C0013-03)Subculture:
1:2 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 degree CFreezing Medium:
Complete culture medium supplemented with 5% (v/v) DMSOBiosafety Level:
I
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
HIV: Negative
Hepatitis B: Negative
Hepatitis C: NegativeSterility:
Pathogens:
References for HUVEC cells:
1. Lemaire, S., Van Bambeke, F., Appelbaum, P. C., and Tulkens, P. M. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. J Antimicrob Chemother, 64: 1035-1043, 2009.
2. Franke, R. P., Fuhrmann, R., Hiebl, B., and Jung, F. Influence of radiographic contrast media on the secretion of vasoactive substances by primary human umbilical venous endothelial cells (HUVEC): prospective, controlled, in vitro comparative study. Clin Hemorheol Microcirc, 43: 181-187, 2009.
3. Chang, C. C., Tsai, S. Y., Lin, H., Li, H. F., Lee, Y. H., Chou, Y., Jen, C. Y., and Juan, S. H. Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene. Cell Mol Life Sci, 66: 3193-3205, 2009.
4. Xue, F. L., Zhang, X., He, G. Y., and Wang, D. H. [Role of nuclear factor-kappaB in apoptosis pathway of HUVEC]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 25: 383-386, 2009.
5. Zhou, L. J. and Liu, J. [Effects of homocysteine on caveolin-1 protein and mRNA gene expression in HUVEC]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 25: 322-324, 2009.
6. Samarzija, I., Sini, P., Schlange, T., Macdonald, G., and Hynes, N. E. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun, 386: 449-454, 2009.
7. Ruf, T. F., Quintes, S., Sternik, P., and Gottmann, U. Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway. Clin Invest Med, 32: E219-228, 2009.
